Bangladesh Pharmaceutical Sector Overview
​Bangladesh is the 44th largest economy of the world in nominal terms and also one of fastest growing economies. Pharmaceutical  as one of its key sectors has a very promising future. This report aims to provide a picture of one of the fastest growing industries of Bangladesh. The pharmaceutical sector of Bangladesh is almost self-sufficient and presents huge export opportunity. In this report we presented the major players of the industry, most sold pharmaceutical products, current export scenario, current backward integration condition and expectations in the future, total healthcare expenditure condition at present, regulatory regime of the industry, and future potential and major challenges to be faced by the industry.
LankaBangla Investments Limited (LBIL) is one of the leading investment banks of Bangladesh. It is a subsidiary of LankaBangla Finance Limited which is one of the largest and fastest growing NBFIs in Bangladesh. Our sister concerns include LankaBangla Securities Limited which is the largest brokerage house in the country and LankaBangla Asset Management Company Limited which is a growing asset management company in the country. LankaBangla group as a whole is a pioneer in the filed of capital market research.
We began our journey as a separate subsidiary in 2010, inheriting our parent company LankaBangla Finance's investment banking operations.Since then, we at LBIL have positioned ourselves prominently in investment banking through our wide range of investment banking products and services and broad client base. We provides services in the area of Portfolio Management, Issue Management, and Investment banking services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.